The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?
about
A novel L1 retrotransposon marker for HeLa cell line identificationCurrent Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of CancerStandards for Cell Line Authentication and BeyondHepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell LinesReproducibility: changing the policies and culture of cell line authenticationMatch criteria for human cell line authentication: where do we draw the line?Human mini-guts: new insights into intestinal physiology and host-pathogen interactionsChoosing the right cell line for renal cell cancer researchEstablishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model systemThe Economics of Reproducibility in Preclinical ResearchReplication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsReplication Study: Melanoma genome sequencing reveals frequent PREX2 mutationsReplication Study: BET bromodomain inhibition as a therapeutic strategy to target c-MycReplication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression dataReplication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsLook back in anger - what clinical studies tell us about preclinical workEstablishment and characterisation of a novel bovine SV40 large T-antigen-transduced foetal hepatocyte-derived cell line.Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assaysClinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimensIs cell culture a risky business? Risk analysis based on scientist survey data.Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2.Primary cell lines: false representation or model system? a comparison of four human colorectal tumors and their coordinately established cell linesUse of cryopreserved cell aliquots in the high-throughput screening of small interfering RNA libraries.Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening.Unauthorized horizontal spread in the laboratory environment: the tactics of Lula, a temperate lambdoid bacteriophage of Escherichia coli.siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption.Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation.UM-SCC-103: a unique tongue cancer cell line that recapitulates the tumorigenic stem cell population of the primary tumorCtr1 is an apical copper transporter in mammalian intestinal epithelial cells in vivo that is controlled at the level of protein stabilityCell-cell signaling in co-cultures of macrophages and fibroblasts.Long term culture of MDCK strains alters chromosome content.Cross-contamination of a UROtsa stock with T24 cells--molecular comparison of different cell lines and stocksOn the reproducibility of science: unique identification of research resources in the biomedical literatureCapturing the regenerative potential of periodontal ligament fibroblastsImplications of cultured periodontal ligament cells for the clinical and experimental setting: a review.Species identification and authentification of human and rodent cell cultures using polymerase chain reaction analysis of vomeronasal receptor genes.A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines
P2860
P800
Q24646099-FBE233B4-A65B-41C3-8036-742D66CF54A1Q26796389-2FA955C7-6A2D-4354-8073-8CD73D561FF8Q27342403-EB6FABFB-2E30-4A77-8003-E1B19FEE0907Q27489071-45F3DD7F-ACB4-4B67-99AD-B345A85EC905Q27910523-4946379F-752E-404B-AC46-F3F83ADE0FA0Q27910530-58BA8B63-13EB-428A-9196-F9CF80E289C8Q28066574-D2B6332E-9559-4AE5-B1ED-803D48F748ABQ28073283-654EE565-08E8-48F1-8DF6-76C731E06399Q28485145-1A2E156B-029B-414B-B155-36715864A8D1Q28548038-A2B2A1AC-91C9-4367-8485-61C8F44DE91EQ28559652-FCA6F025-771E-46CA-86A7-C480A6E59DC7Q28559662-AECF6868-BC38-403E-810D-2B7B79E04651Q28559676-92BBE402-DBB5-4DE5-8D2C-3153359BDCD6Q28559693-262FCF77-4FC3-454B-BA12-4A3AF4248F24Q28559700-0976013E-51E4-42B6-85A7-EB6C40410186Q28677000-23E359F0-04A0-4495-AE09-365B70768C45Q30315255-99247CA1-B4A1-4B7C-B631-70182CAED473Q30389713-F71702A0-F20A-4084-B283-330AAA17EFB6Q30416415-54DF4B53-3366-4FA5-AE5E-C55355185B1FQ30993308-E0907AD9-1A5C-4216-9C07-DB014DB136BDQ33474850-3EB786E7-AD1A-4858-9F01-D2936920FD52Q33549721-C88880FF-15CB-412E-8389-BA114F79B8A3Q33550033-285B760B-227D-41CA-BE68-19767DF3CC88Q33707821-0A5BB347-9843-495A-B1F3-7262B1D60CE8Q33842529-30530077-A3F1-44DD-BAD0-18A57C6D0C3BQ33903540-B68E4632-2440-4A12-A1F9-B2835EE40645Q33912292-B6331B83-12CC-487D-BFBC-D05AF02E014EQ33912421-337F2805-4C8F-408E-99A5-1216860B0627Q33940195-CC3D0C16-2390-4EDC-BF91-49DA937A8869Q34038185-002D61F3-A6C7-4EFF-90FA-FEBA5CF55A4AQ34127978-03BC56D7-694A-443A-83CC-6089C0AA6D07Q34186551-861DECD0-C9FA-4716-A336-5BF98046B86FQ34293050-1A8E73E7-13F2-4068-811D-BC60D993D719Q34687535-65154CB7-562E-41AA-AA7C-3AB5C7A02E70Q34731286-3E2CD397-62E9-477A-83A4-9ACE53E6A26CQ34986389-4EB2AFF3-1A4B-4AEA-B23F-B5287669C81AQ35086450-AAC83279-AB62-4F9C-9D8F-F216D0E34433Q35093588-808E5219-5834-4C2E-8654-D7FDA54D5B66Q35552306-FF35883E-F8E5-48C2-A02F-E1C5882AA456Q35626593-464A3810-ECB2-4338-BB9B-D5EA7C9C56C8
P2860
The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
The costs of using unauthentic ...... how much more data do we need?
@ast
The costs of using unauthentic ...... how much more data do we need?
@en
The costs of using unauthentic ...... how much more data do we need?
@nl
type
label
The costs of using unauthentic ...... how much more data do we need?
@ast
The costs of using unauthentic ...... how much more data do we need?
@en
The costs of using unauthentic ...... how much more data do we need?
@nl
prefLabel
The costs of using unauthentic ...... how much more data do we need?
@ast
The costs of using unauthentic ...... how much more data do we need?
@en
The costs of using unauthentic ...... how much more data do we need?
@nl
P2093
P3181
P356
P1433
P1476
The costs of using unauthentic ...... how much more data do we need?
@en
P2093
Cohava Gelber
Damian Marshall
Helen Parkes
Peyton Hughes
Yvonne Reid
P304
575, 577-8, 581-2 passim
P3181
P356
10.2144/000112598
P577
2007-11-01T00:00:00Z